Mechanism of Tuberculostasis in Mammalian Serum III. Neutralization of Serum Tuberculostasis by Mycobactin
Overview
Authors
Affiliations
Tubercle bacilli exposed to an iron-poor medium multiplied at a slower rate but released more of the serum-tuberculostasis neutralizing factor (TNF) than the bacilli in an iron-rich medium. This growth-promoting factor found in spent medium exhibited characteristics which suggested its relationship to or identity with mycobactin. The identity of these two bacillary products was established by showing that both iron-free mycobactin and TNF promoted bacillary multiplication in tuberculostatic serum. This study resolved a long-standing controversy as to whether mycobactin serves as a growth factor or as a carrier of iron for tubercle bacilli. It was found that the tuberculostasis in mycobactin-neutralized serum was reconstituted by the addition of iron-free transferrin (Tr). The investigation of the interplay between mycobactin and Tr revealed that mycobactin does not serve as a growth factor but as a carrier of growth-essential iron which mycobactin (as contrasted to Tr) provides to tubercle bacilli in a utilizable form.
Iron Supplementation Therapy, A Friend and Foe of Mycobacterial Infections?.
Agoro R, Mura C Pharmaceuticals (Basel). 2019; 12(2).
PMID: 31108902 PMC: 6630247. DOI: 10.3390/ph12020075.
Iron-Binding Catechols and Virulence in Escherichia coli.
Rogers H Infect Immun. 1973; 7(3):445-56.
PMID: 16558077 PMC: 422698. DOI: 10.1128/iai.7.3.445-456.1973.
Wong D, Lee B, Horwitz M, Gibson B Infect Immun. 1998; 67(1):327-36.
PMID: 9864233 PMC: 96314. DOI: 10.1128/IAI.67.1.327-336.1999.
Bricard L, Ramiandrasoa F, Deroussent A, Kunesch G, Andremont A Antimicrob Agents Chemother. 1997; 41(8):1837-9.
PMID: 9257775 PMC: 164019. DOI: 10.1128/AAC.41.8.1837.
Gobin J, Moore C, Reeve Jr J, Wong D, Gibson B, Horwitz M Proc Natl Acad Sci U S A. 1995; 92(11):5189-93.
PMID: 7761471 PMC: 41874. DOI: 10.1073/pnas.92.11.5189.